▶ 調査レポート

希少内分泌疾患治療の世界市場（～2026年）
• 英文タイトル：Global Rare Endocrine Disease Treatment Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。希少内分泌疾患治療の世界市場（～2026年） / Global Rare Endocrine Disease Treatment Market Size, Status and Forecast 2020-2026 / MRC2-11QY04459資料のイメージです。• レポートコード：MRC2-11QY04459
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、94ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア
• 販売価格（消費税別）
  Single User￥585,000 (USD3,900)▷ お問い合わせ
  Multi User￥877,500 (USD5,850)▷ お問い合わせ
  Enterprise License￥1,170,000 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当調査資料は希少内分泌疾患治療のグローバル市場について調査・分析したレポートです。種類別（生物製剤、有機化合物）市場規模、用途別（病院薬局、オンライン薬局、小売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別希少内分泌疾患治療の競争状況、市場シェア
・世界の希少内分泌疾患治療市場：種類別市場規模 2015年-2020年（生物製剤、有機化合物）
・世界の希少内分泌疾患治療市場：種類別市場規模予測 2021年-2026年（生物製剤、有機化合物）
・世界の希少内分泌疾患治療市場：用途別市場規模 2015年-2020年（病院薬局、オンライン薬局、小売薬局）
・世界の希少内分泌疾患治療市場：用途別市場規模予測 2021年-2026年（病院薬局、オンライン薬局、小売薬局）
・北米の希少内分泌疾患治療市場分析：米国、カナダ
・ヨーロッパの希少内分泌疾患治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの希少内分泌疾患治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の希少内分泌疾患治療市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの希少内分泌疾患治療市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Novartis、Ipsen、Pfizer、Teva、EMD Serono、Novo Nordisk、Eli Lilly、Takeda、Amgen、Corcept Therapeutics、Novelion Therapeutics
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

The endocrine system is a chemical messenger system consisting of hormones, the group of glands of an organism that carry those hormones directly into the circulatory system to be carried towards distant target organs and the feedback loops of homeostasis that the hormones drive.
The rare endocrine disease treatment market is expected to grow rapidly over the forecast period owing to the increasing prevalence of rare endocrine diseases.

Market Analysis and Insights: Global Rare Endocrine Disease Treatment Market
The global Rare Endocrine Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Rare Endocrine Disease Treatment Scope and Market Size
Rare Endocrine Disease Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Rare Endocrine Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Novartis
Ipsen
Pfizer
Teva
EMD Serono
Novo Nordisk
Eli Lilly
Takeda
Amgen
Corcept Therapeutics
Novelion Therapeutics

Market segment by Type, the product can be split into
Biologics
Organic Compounds
Market segment by Application, split into
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Rare Endocrine Disease Treatment Revenue
1.4 Market by Type
1.4.1 Global Rare Endocrine Disease Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Biologics
1.4.3 Organic Compounds
1.5 Market by Application
1.5.1 Global Rare Endocrine Disease Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Online Pharmacies
1.5.4 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Rare Endocrine Disease Treatment Market Perspective (2015-2026)
2.2 Global Rare Endocrine Disease Treatment Growth Trends by Regions
2.2.1 Rare Endocrine Disease Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Rare Endocrine Disease Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Rare Endocrine Disease Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Rare Endocrine Disease Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Rare Endocrine Disease Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Rare Endocrine Disease Treatment Players by Market Size
3.1.1 Global Top Rare Endocrine Disease Treatment Players by Revenue (2015-2020)
3.1.2 Global Rare Endocrine Disease Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Rare Endocrine Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Rare Endocrine Disease Treatment Market Concentration Ratio
3.2.1 Global Rare Endocrine Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Rare Endocrine Disease Treatment Revenue in 2019
3.3 Rare Endocrine Disease Treatment Key Players Head office and Area Served
3.4 Key Players Rare Endocrine Disease Treatment Product Solution and Service
3.5 Date of Enter into Rare Endocrine Disease Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Rare Endocrine Disease Treatment Historic Market Size by Type (2015-2020)
4.2 Global Rare Endocrine Disease Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Rare Endocrine Disease Treatment Market Size by Application (2015-2020)
5.2 Global Rare Endocrine Disease Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Rare Endocrine Disease Treatment Market Size (2015-2020)
6.2 Rare Endocrine Disease Treatment Key Players in North America (2019-2020)
6.3 North America Rare Endocrine Disease Treatment Market Size by Type (2015-2020)
6.4 North America Rare Endocrine Disease Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Rare Endocrine Disease Treatment Market Size (2015-2020)
7.2 Rare Endocrine Disease Treatment Key Players in Europe (2019-2020)
7.3 Europe Rare Endocrine Disease Treatment Market Size by Type (2015-2020)
7.4 Europe Rare Endocrine Disease Treatment Market Size by Application (2015-2020)

8 China
8.1 China Rare Endocrine Disease Treatment Market Size (2015-2020)
8.2 Rare Endocrine Disease Treatment Key Players in China (2019-2020)
8.3 China Rare Endocrine Disease Treatment Market Size by Type (2015-2020)
8.4 China Rare Endocrine Disease Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Rare Endocrine Disease Treatment Market Size (2015-2020)
9.2 Rare Endocrine Disease Treatment Key Players in Japan (2019-2020)
9.3 Japan Rare Endocrine Disease Treatment Market Size by Type (2015-2020)
9.4 Japan Rare Endocrine Disease Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Rare Endocrine Disease Treatment Market Size (2015-2020)
10.2 Rare Endocrine Disease Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Rare Endocrine Disease Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Rare Endocrine Disease Treatment Market Size by Application (2015-2020)

11 India
11.1 India Rare Endocrine Disease Treatment Market Size (2015-2020)
11.2 Rare Endocrine Disease Treatment Key Players in India (2019-2020)
11.3 India Rare Endocrine Disease Treatment Market Size by Type (2015-2020)
11.4 India Rare Endocrine Disease Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Rare Endocrine Disease Treatment Market Size (2015-2020)
12.2 Rare Endocrine Disease Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Rare Endocrine Disease Treatment Market Size by Type (2015-2020)
12.4 Central & South America Rare Endocrine Disease Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Novartis
13.1.1 Novartis Company Details
13.1.2 Novartis Business Overview
13.1.3 Novartis Rare Endocrine Disease Treatment Introduction
13.1.4 Novartis Revenue in Rare Endocrine Disease Treatment Business (2015-2020))
13.1.5 Novartis Recent Development
13.2 Ipsen
13.2.1 Ipsen Company Details
13.2.2 Ipsen Business Overview
13.2.3 Ipsen Rare Endocrine Disease Treatment Introduction
13.2.4 Ipsen Revenue in Rare Endocrine Disease Treatment Business (2015-2020)
13.2.5 Ipsen Recent Development
13.3 Pfizer
13.3.1 Pfizer Company Details
13.3.2 Pfizer Business Overview
13.3.3 Pfizer Rare Endocrine Disease Treatment Introduction
13.3.4 Pfizer Revenue in Rare Endocrine Disease Treatment Business (2015-2020)
13.3.5 Pfizer Recent Development
13.4 Teva
13.4.1 Teva Company Details
13.4.2 Teva Business Overview
13.4.3 Teva Rare Endocrine Disease Treatment Introduction
13.4.4 Teva Revenue in Rare Endocrine Disease Treatment Business (2015-2020)
13.4.5 Teva Recent Development
13.5 EMD Serono
13.5.1 EMD Serono Company Details
13.5.2 EMD Serono Business Overview
13.5.3 EMD Serono Rare Endocrine Disease Treatment Introduction
13.5.4 EMD Serono Revenue in Rare Endocrine Disease Treatment Business (2015-2020)
13.5.5 EMD Serono Recent Development
13.6 Novo Nordisk
13.6.1 Novo Nordisk Company Details
13.6.2 Novo Nordisk Business Overview
13.6.3 Novo Nordisk Rare Endocrine Disease Treatment Introduction
13.6.4 Novo Nordisk Revenue in Rare Endocrine Disease Treatment Business (2015-2020)
13.6.5 Novo Nordisk Recent Development
13.7 Eli Lilly
13.7.1 Eli Lilly Company Details
13.7.2 Eli Lilly Business Overview
13.7.3 Eli Lilly Rare Endocrine Disease Treatment Introduction
13.7.4 Eli Lilly Revenue in Rare Endocrine Disease Treatment Business (2015-2020)
13.7.5 Eli Lilly Recent Development
13.8 Takeda
13.8.1 Takeda Company Details
13.8.2 Takeda Business Overview
13.8.3 Takeda Rare Endocrine Disease Treatment Introduction
13.8.4 Takeda Revenue in Rare Endocrine Disease Treatment Business (2015-2020)
13.8.5 Takeda Recent Development
13.9 Amgen
13.9.1 Amgen Company Details
13.9.2 Amgen Business Overview
13.9.3 Amgen Rare Endocrine Disease Treatment Introduction
13.9.4 Amgen Revenue in Rare Endocrine Disease Treatment Business (2015-2020)
13.9.5 Amgen Recent Development
13.10 Corcept Therapeutics
13.10.1 Corcept Therapeutics Company Details
13.10.2 Corcept Therapeutics Business Overview
13.10.3 Corcept Therapeutics Rare Endocrine Disease Treatment Introduction
13.10.4 Corcept Therapeutics Revenue in Rare Endocrine Disease Treatment Business (2015-2020)
13.10.5 Corcept Therapeutics Recent Development
13.11 Novelion Therapeutics
10.11.1 Novelion Therapeutics Company Details
10.11.2 Novelion Therapeutics Business Overview
10.11.3 Novelion Therapeutics Rare Endocrine Disease Treatment Introduction
10.11.4 Novelion Therapeutics Revenue in Rare Endocrine Disease Treatment Business (2015-2020)
10.11.5 Novelion Therapeutics Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Rare Endocrine Disease Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Rare Endocrine Disease Treatment Revenue
Table 3. Ranking of Global Top Rare Endocrine Disease Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Rare Endocrine Disease Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Biologics
Table 6. Key Players of Organic Compounds
Table 7. Global Rare Endocrine Disease Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Rare Endocrine Disease Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Rare Endocrine Disease Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Rare Endocrine Disease Treatment Market Share by Regions (2015-2020)
Table 11. Global Rare Endocrine Disease Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Rare Endocrine Disease Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Rare Endocrine Disease Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Rare Endocrine Disease Treatment Players
Table 18. Global Rare Endocrine Disease Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Rare Endocrine Disease Treatment Market Share by Players (2015-2020)
Table 20. Global Top Rare Endocrine Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rare Endocrine Disease Treatment as of 2019)
Table 21. Global Rare Endocrine Disease Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Rare Endocrine Disease Treatment Product Solution and Service
Table 24. Date of Enter into Rare Endocrine Disease Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Rare Endocrine Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Rare Endocrine Disease Treatment Market Size Share by Type (2015-2020)
Table 28. Global Rare Endocrine Disease Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Rare Endocrine Disease Treatment Market Size Share by Application (2015-2020)
Table 30. Global Rare Endocrine Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Rare Endocrine Disease Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Rare Endocrine Disease Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Rare Endocrine Disease Treatment Market Share (2019-2020)
Table 34. North America Rare Endocrine Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Rare Endocrine Disease Treatment Market Share by Type (2015-2020)
Table 36. North America Rare Endocrine Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Rare Endocrine Disease Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Rare Endocrine Disease Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Rare Endocrine Disease Treatment Market Share (2019-2020)
Table 40. Europe Rare Endocrine Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Rare Endocrine Disease Treatment Market Share by Type (2015-2020)
Table 42. Europe Rare Endocrine Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Rare Endocrine Disease Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Rare Endocrine Disease Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Rare Endocrine Disease Treatment Market Share (2019-2020)
Table 46. China Rare Endocrine Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Rare Endocrine Disease Treatment Market Share by Type (2015-2020)
Table 48. China Rare Endocrine Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Rare Endocrine Disease Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Rare Endocrine Disease Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Rare Endocrine Disease Treatment Market Share (2019-2020)
Table 52. Japan Rare Endocrine Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Rare Endocrine Disease Treatment Market Share by Type (2015-2020)
Table 54. Japan Rare Endocrine Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Rare Endocrine Disease Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Rare Endocrine Disease Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Rare Endocrine Disease Treatment Market Share (2019-2020)
Table 58. Southeast Asia Rare Endocrine Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Rare Endocrine Disease Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Rare Endocrine Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Rare Endocrine Disease Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Rare Endocrine Disease Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Rare Endocrine Disease Treatment Market Share (2019-2020)
Table 64. India Rare Endocrine Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Rare Endocrine Disease Treatment Market Share by Type (2015-2020)
Table 66. India Rare Endocrine Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Rare Endocrine Disease Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Rare Endocrine Disease Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Rare Endocrine Disease Treatment Market Share (2019-2020)
Table 70. Central & South America Rare Endocrine Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Rare Endocrine Disease Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Rare Endocrine Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Rare Endocrine Disease Treatment Market Share by Application (2015-2020)
Table 74. Novartis Company Details
Table 75. Novartis Business Overview
Table 76. Novartis Product
Table 77. Novartis Revenue in Rare Endocrine Disease Treatment Business (2015-2020) (Million US$)
Table 78. Novartis Recent Development
Table 79. Ipsen Company Details
Table 80. Ipsen Business Overview
Table 81. Ipsen Product
Table 82. Ipsen Revenue in Rare Endocrine Disease Treatment Business (2015-2020) (Million US$)
Table 83. Ipsen Recent Development
Table 84. Pfizer Company Details
Table 85. Pfizer Business Overview
Table 86. Pfizer Product
Table 87. Pfizer Revenue in Rare Endocrine Disease Treatment Business (2015-2020) (Million US$)
Table 88. Pfizer Recent Development
Table 89. Teva Company Details
Table 90. Teva Business Overview
Table 91. Teva Product
Table 92. Teva Revenue in Rare Endocrine Disease Treatment Business (2015-2020) (Million US$)
Table 93. Teva Recent Development
Table 94. EMD Serono Company Details
Table 95. EMD Serono Business Overview
Table 96. EMD Serono Product
Table 97. EMD Serono Revenue in Rare Endocrine Disease Treatment Business (2015-2020) (Million US$)
Table 98. EMD Serono Recent Development
Table 99. Novo Nordisk Company Details
Table 100. Novo Nordisk Business Overview
Table 101. Novo Nordisk Product
Table 102. Novo Nordisk Revenue in Rare Endocrine Disease Treatment Business (2015-2020) (Million US$)
Table 103. Novo Nordisk Recent Development
Table 104. Eli Lilly Company Details
Table 105. Eli Lilly Business Overview
Table 106. Eli Lilly Product
Table 107. Eli Lilly Revenue in Rare Endocrine Disease Treatment Business (2015-2020) (Million US$)
Table 108. Eli Lilly Recent Development
Table 109. Takeda Business Overview
Table 110. Takeda Product
Table 111. Takeda Company Details
Table 112. Takeda Revenue in Rare Endocrine Disease Treatment Business (2015-2020) (Million US$)
Table 113. Takeda Recent Development
Table 114. Amgen Company Details
Table 115. Amgen Business Overview
Table 116. Amgen Product
Table 117. Amgen Revenue in Rare Endocrine Disease Treatment Business (2015-2020) (Million US$)
Table 118. Amgen Recent Development
Table 119. Corcept Therapeutics Company Details
Table 120. Corcept Therapeutics Business Overview
Table 121. Corcept Therapeutics Product
Table 122. Corcept Therapeutics Revenue in Rare Endocrine Disease Treatment Business (2015-2020) (Million US$)
Table 123. Corcept Therapeutics Recent Development
Table 124. Novelion Therapeutics Company Details
Table 125. Novelion Therapeutics Business Overview
Table 126. Novelion Therapeutics Product
Table 127. Novelion Therapeutics Revenue in Rare Endocrine Disease Treatment Business (2015-2020) (Million US$)
Table 128. Novelion Therapeutics Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rare Endocrine Disease Treatment Market Share by Type: 2020 VS 2026
Figure 2. Biologics Features
Figure 3. Organic Compounds Features
Figure 4. Global Rare Endocrine Disease Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Online Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Rare Endocrine Disease Treatment Report Years Considered
Figure 9. Global Rare Endocrine Disease Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Rare Endocrine Disease Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Rare Endocrine Disease Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Rare Endocrine Disease Treatment Market Share by Players in 2019
Figure 14. Global Top Rare Endocrine Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rare Endocrine Disease Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Rare Endocrine Disease Treatment Revenue in 2019
Figure 16. North America Rare Endocrine Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Rare Endocrine Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Rare Endocrine Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Rare Endocrine Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Rare Endocrine Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Rare Endocrine Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Rare Endocrine Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed

以下、関連資料のご紹介
  • 希少神経疾患治療の世界市場（～2026年）
    Global Rare Neurological Disease Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY04460 2020年11月20日 98Pages
    当調査資料は希少神経疾患治療のグローバル市場について調査・分析したレポートです。種類別（生物製剤、有機化合物）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オース...
  • 希少疾患治療の世界市場（～2026年）
    Global Rare Disease Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY04458 2020年11月20日 129Pages
    当調査資料は希少疾患治療のグローバル市場について調査・分析したレポートです。種類別（オリジネーター医薬品、ジェネリック医薬品）市場規模、用途別（病院薬局、専門薬局、小売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、イン...
  • クラッベ病治療の世界市場（～2026年）
    Global Krabbe Disease Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY12467 2020年11月25日 94Pages
    当調査資料はクラッベ病治療のグローバル市場について調査・分析したレポートです。種類別（抗けいれん薬、筋弛緩薬、造血幹細胞移植、その他）市場規模、用途別（病院、ASC）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オー...
  • クッシング病治療の世界市場（～2026年）
    Global Cushing’s Disease Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY11540 2020年11月25日 99Pages
    当調査資料はクッシング病治療のグローバル市場について調査・分析したレポートです。種類別（ケトコナゾール、ミトタン、アミノグルテチミド、メチラポン、ミフェプリストン、エトミデート、パシレオチド）市場規模、用途別（病院薬局、小売薬局、ドラッグストア、クリニック、Eコマース/オンライン薬局）市場規模、地域...
  • ニューカッスル病治療の世界市場（～2026年）
    Global Newcastle Disease Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY03968 2020年11月20日 99Pages
    当調査資料はニューカッスル病治療のグローバル市場について調査・分析したレポートです。種類別（弱毒生ワクチン、不活化ワクチン、複合ワクチン）市場規模、用途別（獣医病院、獣医クリニック、獣医研究所、小売薬局、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、...
  • 感染症治療の世界市場（～2026年）
    Global Infectious Disease Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY12367 2020年11月25日 91Pages
    当調査資料は感染症治療のグローバル市場について調査・分析したレポートです。種類別（抗菌、抗真菌薬、抗ウイルス薬）市場規模、用途別（病院・クリニック、小売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリ...
  • レイノー病治療の世界市場（～2026年）
    Global Raynauds Disease Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY04462 2020年11月20日 91Pages
    当調査資料はレイノー病治療のグローバル市場について調査・分析したレポートです。種類別（アセチルシステイン、アルプロスタジル、ELS-140、ネオバスカルゲン、ニトログリセリン、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス...
  • 人獣共通感染症治療の世界市場（～2026年）
    Global Zoonotic Disease Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY05134 2020年11月20日 93Pages
    当調査資料は人獣共通感染症治療のグローバル市場について調査・分析したレポートです。種類別（ウイルス性肝炎、狂犬病、回帰熱、結核、マラリア）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、イン...
  • ポンペ病治療の世界市場（～2026年）
    Global Pompe Disease Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY04326 2020年11月20日 95Pages
    当調査資料はポンペ病治療のグローバル市場について調査・分析したレポートです。種類別（乳児期発症ポンペ病、成人発症ポンペ病）市場規模、用途別（病院、医療センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オ...
  • ベーチェット病治療の世界市場（～2026年）
    Global Behcet Disease Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY11034 2020年11月25日 98Pages
    当調査資料はベーチェット病治療のグローバル市場について調査・分析したレポートです。種類別（アダリムマブバイオシミラー、アプレミラスト、カナキヌマブ、インフリキシマブバイオシミラー、その他）市場規模、用途別（在宅介護、病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス...
  • 希少神経疾患治療の世界市場（～2026年）希少神経疾患治療の世界市場（～2026年） Market Analysis and Insights: Global Rare Neurological Disease Treatment Market The global Rare Neurological Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Rare Neurological Disease Treatment Scope a…
  • 希少疾患治療の世界市場（～2026年）希少疾患治療の世界市場（～2026年） A rare disease is any disease that affects a small percentage of the population. Most rare diseases are genetic and thus are present throughout the person's entire life, even if symptoms do not immediately appear. Market Analysis and Insights: Global Rare Disease Treatment Market The global Rare Dis…
  • クッシング病治療の世界市場（～2026年）クッシング病治療の世界市場（～2026年） Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal wit…
  • 筋萎縮性側索硬化症（ルーゲーリック病）治療の世界市場（～2026年）筋萎縮性側索硬化症（ルーゲーリック病）治療の世界市場（～2026年） Amyotrophic Lateral Sclerosis (ALS) is a neurological disease that affects nerve cells in the brain and spinal cords which controls the activity of voluntary muscles. It is also termed as Lou Gehrig’s disease. There are several causes behind ALS which includes gene mutation, disorganized immune resp…
  • ニューカッスル病治療の世界市場（～2026年）ニューカッスル病治療の世界市場（～2026年） Newcastle Disease is a highly contagious disease of avian species especially poultry caused by avian Paramyxovirus type 1 (APMV-1). The North America is dominating and contributed the leading shares to the global Newcastle Disease Treatment market in terms of revenue and expected to register a signi…